Browsing: Compelling

This article was written byFollowI have been involved in the financial world for over 25 years with experience as an advisor, teacher, and writer. I am…

This article was written byFollowDaniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at analyzing the cash…

This article was written byFollowInvestment research, primarily oriented towards uncelebrated/under-covered stocks and ETFs, across North America, Latin America, Europe and Asia. Seeks to combine both fundamental…

This article was written byFollowI ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets…

This article was written byFollowMy name is Andres Veurink and I have been in the financial markets for over a decade at this point, spending the…

This article was written byFollowI am currently an undergraduate student who will be going into financial services. I’ve had experience in investing through prior PE and…

This article was written byFollowScientist and trader of biotech stock. Focus on trading around events such as trial results and NDA/BLA approvals. Also covering companies in…

This article was written byFollowFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs,…

ET Intelligence Group: Corona Remedies, a pharma company, plans to raise Rs 655.4 crore through an offer for sale. The promoter group’s stake will fall to…

Investors are concerned about this business right now, but it is poised to return to profitability next year.Healthcare has been a painful industry to invest in…